Butanediamide,N4-hydroxy-N1-[2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl]-2-(2-methylpropyl)-3-[(2-thienylsulfonyl)methyl]-,[2R-[1(S*),2R*,3S*]]-
CAS No. 130370-78-4
Butanediamide,N4-hydroxy-N1-[2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl]-2-(2-methylpropyl)-3-[(2-thienylsulfonyl)methyl]-,[2R-[1(S*),2R*,3S*]]-; BB 250
PD-MY 001
51273-94-0
Pentanediamide, 2,4-dibenzoyl-N,N'-diphenyl-
51264-61-0
1-Azido-3-chloro-2-propanol
51275-91-3
sodium fluoride hydrofluoride
51273-71-3
Stannyl, tris[bis(trimethylsilyl)methyl]-
51275-77-5
A-130A
51257-84-2
Acridine, 9-hydrazino-, monoacetate
51274-78-3
norethindrone-4 beta,5 beta-epoxide
51267-63-1
4-IMIDAZOLIDINONE,3-CYCLOHEXYL-1-ETHYL-2-THIOXO-
659734-00-6
9-(β-D-Glucopyranosyl)-trans-zeatin
51255-96-0
angiotensin II, Sar(1)-Val(5)-Ile(8)-
51274-63-6
1H-Indole, 1-butyl-4,5,6,7-tetrahydro-
51265-35-1
2(1H)-Quinoxalinone, 8-hydroxy-
659729-62-1
1,7-octadiene-3,6-diol, 2,6-dimethyl-
51276-33-6
1H-Indole, 4,5,6,7-tetrahydro-1-methyl-
51265-33-9
6,7-Dioxabicyclo(3.2.1)octane
51272-66-3
2(1H)-Quinoxalinone, 8-methoxy-
659729-61-0
2 3-DICHLORO SULFOLANE
51275-92-4
Morpholine, 4-(4,5-dihydro-2-oxazolyl)-
65972-69-2
levonorgestrel-4 beta,5 beta-epoxide
51267-67-5